Who has invested in Bluestar Genomics?

Prosperity Capital Management, Pathology Asia Holdings Pte Ltd are named among the investors backing Bluestar Genomics.

Bluestar Genomics Funding: $70M Raised, Series C (2021)

Bluestar Genomics funding overview

Bluestar Genomics is based in San Diego, CA. Bluestar Genomics has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in May 2021. The round record for Bluestar Genomics runs through 2021; nothing later has been disclosed. Investors on record include Prosperity Capital Management, Pathology Asia Holdings Pte Ltd. 2 distinct backers are named across the disclosed rounds.

Bluestar Genomics at a glance

Total raised: $70M
Latest round: Series C
Latest round date: May 2021
Headquarters: San Diego, CA
Notable investors: Prosperity Capital Management, Pathology Asia Holdings Pte Ltd

Frequently asked about Bluestar Genomics funding

How much has Bluestar Genomics raised?: Bluestar Genomics has raised $70M in total disclosed funding across the rounds on record.
Who has invested in Bluestar Genomics?: Prosperity Capital Management, Pathology Asia Holdings Pte Ltd are named among the investors backing Bluestar Genomics.
What was the latest Bluestar Genomics funding round?: The most recent disclosed round is a Series C, announced in May 2021.
Where is Bluestar Genomics based?: Bluestar Genomics is based in San Diego, CA.
When did Bluestar Genomics last raise?: The last disclosed Bluestar Genomics round closed in May 2021 at Series C.

Totals shown for Bluestar Genomics aggregate every disclosed round on file. To see how that compares, browse the companies in San Diego and the investors behind them below.

Bluestar Genomics Funding: $70M Raised, Series C (2021)

Bluestar Genomics funding overview

Bluestar Genomics at a glance

Frequently asked about Bluestar Genomics funding

Companies related to Bluestar Genomics (18)

Browse related funding lists (5)